VEGFR-TKI Tivozanib: Rational Treatment Selection Post-ICI Progression

Opinion
Video

Experts discuss the rational treatment selection of the VEGFR-tyrosine kinase inhibitor (TKI) tivozanib following progression after immune checkpoint inhibitor (ICI) therapy.

Recent Videos
5 experts in this video
5 experts in this video
Related Content